University of Kentucky researchers plan to start a clinical trial testing a new device from Neuronetrix that could diagnose Alzheimer's disease more accurately and earlier.
Published in Brief:
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan
|Assistant Vice President - Dental Director||
|Vice President of Finance||
Urban Health Plan, Inc.